Lexi Ding
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- Peroxisome Proliferator-Activated Receptors 7
- RNA Research and Splicing 2
- Retinoids in leukemia and cellular processes 2
-
- Retinal Diseases and Treatments 7
- Glaucoma and retinal disorders 2
- Co-authors
- Jian‐xing Ma (9 shared papers)Rui Cheng (8 shared papers)Yusuke Takahashi (5 shared papers)Yang Hu (4 shared papers)Xuemin He (3 shared papers)Ying Chen (2 shared papers)Siqi Xiong (3 shared papers)Xiaobo Xia (3 shared papers)
- Journals
- Frontiers in Endocrinology (5 papers)Investigative Ophthalmology & Visual Science (4 papers)Diabetes (2 papers)Biomedicine & Pharmacotherapy (2 papers)Molecular Therapy (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lexi Ding
24 papers receiving 735 citations
Peers
Comparison fields: 5 of 73
- Ophthalmology 247
- Clinical Biochemistry 77
- Physiology 45
- Neurology 65
- Molecular Biology 422
Countries citing papers authored by Lexi Ding
This map shows the geographic impact of Lexi Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lexi Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lexi Ding more than expected).
Fields of papers citing papers by Lexi Ding
This network shows the impact of papers produced by Lexi Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lexi Ding. The network helps show where Lexi Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Lexi Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 128 | |
| 2 | 2014 | 74 | |
| 3 | 2012 | 69 | |
| 4 | 2014 | 63 | |
| 5 | 2016 | 61 | |
| 6 | 2019 | 50 | |
| 7 | 2022 | 38 | |
| 8 | 2019 | 35 | |
| 9 | 2015 | 35 | |
| 10 | 2022 | 33 | |
| 11 | 2014 | 33 | |
| 12 | 2021 | 24 | |
| 13 | 2020 | 23 | |
| 14 | 2022 | 21 | |
| 15 | 2020 | 18 | |
| 16 | 2017 | 12 | |
| 17 | 2022 | 8 | |
| 18 | 2021 | 8 | |
| 19 | 2022 | 5 | |
| 20 | 2018 | 3 |
About Lexi Ding
Lexi Ding is a scholar working on Molecular Biology, Ophthalmology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 25 papers that have together received 748 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (7 papers), Retinal Diseases and Treatments (7 papers), MicroRNA in disease regulation (2 papers), Glaucoma and retinal disorders (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Advanced Glycation End Products research (2 papers), RNA Research and Splicing (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Ophthalmology (247 citations), Clinical Biochemistry (77 citations), Physiology (45 citations), Neurology (65 citations) and Molecular Biology (422 citations). Lexi Ding has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jian‐xing Ma, Rui Cheng, Yusuke Takahashi, Yang Hu, Xuemin He, Ying Chen, Siqi Xiong, Xiaobo Xia, Kyungwon Lee and Elizabeth Moran. Their work appears in journals such as Frontiers in Endocrinology, Investigative Ophthalmology & Visual Science, Diabetes, Biomedicine & Pharmacotherapy and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.